Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

GBT Sol ICA

By quantitatively analyzing the cluster of differentiating protein markers on the surface of white blood cells, we have developed an immune cell analysis system that can be used for the presence of infection, the progress of disease, and the observation of prognosis over the course of treatment. The system is called the ICA. Through years of research and development, we have developed a product that can quantitatively analyze CD4, CD8 markers that are essential for HIV/AIDS infection, develop a system for analyzing Latent Tuberculus and malaria, and develop CD markers and systems for diagnosing Sepsis.

Traditional white blood cell testing is a step that is analyzed with flowcytometry after a blood centrifuge antigen/antibody reaction, with large amounts of blood, long periods of time, and areas that require skilled equipment users. Our ICA can reduce long, uncomfortable steps to a small amount of blood, so we can use our source technology to isolate and analyze white blood cells in a simple, cost-effective, and effective way. It can also be carried out onsite inspection with a weight of 6kg or less. It can be used as a point-of-care (POC) equipment for 10 to 20 minutes or more